The global Cancer Biomarkers Market is growing due to rising cancer rates, advancements in genomics and proteomics, and increasing demand for personalized medicine. Liquid biopsy and multi-marker panels are gaining traction for early detection and precision oncology. More Info: https://www.imarcgroup.com/cancer-biomarkers-market